Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
Clinical trial NCT05128383 · COMPLETED
Trial details
- NCT number
- NCT05128383
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2025-05-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.